Intermittent Cold Exposure and Brown Adipose Tissue Hyperplasia
Launched by UNIVERSITY OF EDINBURGH · Jun 30, 2025
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how short periods of cold exposure affect a special type of fat in the body called brown adipose tissue (or BAT), which helps generate heat and burn energy. Researchers want to see how cold exposure changes the activity and function of BAT, as well as muscle and regular fat (white adipose tissue), by looking at tissue samples and scans before and after the cold exposure. They are also interested in whether cold exposure improves how the body uses energy, increases tolerance to cold, and reduces inflammation.
Adults between 18 and 40 years old who are healthy, have a normal body weight, and meet certain health criteria may be eligible to participate. Over about two weeks, participants will come in for initial tests including scans and small tissue samples, then undergo 10 days of cold exposure for two hours each day using special cooling blankets. After this, they will have follow-up tests to see how their bodies have changed. The study is currently recruiting volunteers who do not have medical issues, take regular medications (except birth control for women), or have problems like claustrophobia that would make scans difficult. This study helps us understand how cold exposure might activate beneficial fat tissue and improve overall health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 18-40 years
- • Body mass index 18.5-25 kg/m2
- • Weight change of less than 5% in the past 6 months
- • No acute or chronic medical conditions
- • On no regular medications (other than contraceptives in female participants)
- • No claustrophobia
- • Alcohol intake ≤14 units/ week
- • Screening blood tests within acceptable limits (of no clinical significance)
- • Not currently pregnant, lactating or breastfeeding (female participants only)
- • Ability to provide informed consent.
- Exclusion Criteria:
- • Not meeting inclusion criteria
- • Contra-indication to PET/CT scan
- • Allergy to local anaesthetic
About University Of Edinburgh
The University of Edinburgh, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a leading clinical trial sponsor dedicated to advancing healthcare through rigorous scientific inquiry. With a strong emphasis on multidisciplinary collaboration, the university facilitates cutting-edge clinical studies that aim to explore novel therapies and improve patient outcomes. Leveraging its extensive network of researchers, healthcare professionals, and state-of-the-art facilities, the University of Edinburgh is at the forefront of translating scientific discoveries into practical applications, thereby contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edinburgh, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported